Area of research
Oncology · Reproductive Medicine
Research interest
Research interests include Cancer Treatment and Pharmacology, Ovarian cancer diagnosis and treatment, Neuroendocrine Tumor Research Advances, and Breast Cancer Treatment Studies.
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
Prognostic gene expression signature for high-grade serous ovarian cancer
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours